IBM T. J. Watson Research Center, Yorktown Heights, NY, USA.
IBM Almaden Research Center, San Jose, CA, USA.
Sci Rep. 2021 Mar 19;11(1):6433. doi: 10.1038/s41598-021-85750-0.
In response to the ongoing global pandemic, characterizing the molecular-level host interactions of the new coronavirus SARS-CoV-2 responsible for COVID-19 has been at the center of unprecedented scientific focus. However, when the virus enters the body it also interacts with the micro-organisms already inhabiting the host. Understanding the virus-host-microbiome interactions can yield additional insights into the biological processes perturbed by viral invasion. Alterations in the gut microbiome species and metabolites have been noted during respiratory viral infections, possibly impacting the lungs via gut-lung microbiome crosstalk. To better characterize microbial functions in the lower respiratory tract during COVID-19 infection, we carry out a functional analysis of previously published metatranscriptome sequencing data of bronchoalveolar lavage fluid from eight COVID-19 cases, twenty-five community-acquired pneumonia patients, and twenty healthy controls. The functional profiles resulting from comparing the sequences against annotated microbial protein domains clearly separate the cohorts. By examining the associated metabolic pathways, distinguishing functional signatures in COVID-19 respiratory tract microbiomes are identified, including decreased potential for lipid metabolism and glycan biosynthesis and metabolism pathways, and increased potential for carbohydrate metabolism pathways. The results include overlap between previous studies on COVID-19 microbiomes, including decrease in the glycosaminoglycan degradation pathway and increase in carbohydrate metabolism. The results also suggest novel connections to consider, possibly specific to the lower respiratory tract microbiome, calling for further research on microbial functions and host-microbiome interactions during SARS-CoV-2 infection.
针对当前全球大流行的情况,对引发 COVID-19 的新型冠状病毒 SARS-CoV-2 的分子水平的宿主相互作用进行特征描述,这是前所未有的科学重点。然而,当病毒进入人体时,它也会与已经存在于宿主中的微生物相互作用。了解病毒-宿主-微生物组的相互作用可以进一步深入了解病毒入侵扰乱的生物学过程。在呼吸道病毒感染期间,肠道微生物组的物种和代谢物发生改变,这可能通过肠道-肺部微生物组串扰影响肺部。为了更好地描述 COVID-19 感染期间下呼吸道的微生物功能,我们对之前发表的 8 例 COVID-19 病例、25 例社区获得性肺炎患者和 20 名健康对照的支气管肺泡灌洗液的宏转录组测序数据进行了功能分析。通过将序列与注释的微生物蛋白结构域进行比较得出的功能图谱清楚地区分了队列。通过检查相关的代谢途径,确定了 COVID-19 呼吸道微生物组的功能特征,包括脂质代谢和聚糖生物合成与代谢途径的潜力降低,以及碳水化合物代谢途径的潜力增加。研究结果包括先前关于 COVID-19 微生物组的研究之间的重叠,包括糖胺聚糖降解途径的减少和碳水化合物代谢的增加。研究结果还表明,需要进一步研究微生物功能和 SARS-CoV-2 感染期间的宿主-微生物组相互作用,以考虑可能特定于下呼吸道微生物组的新联系。